Deep learning enables rapid identification of potent DDR1 kinase inhibitors; Applications of deep learning in biomedicine; Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data; The role of DNA damage and repair in aging through the prism of Koch-like criteria; druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico; Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare; Molecular sets (MOSES): a benchmarking platform for molecular generation models; The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology; Deep biomarkers of human aging: application of deep neural networks to biomarker development; Reinforced Adversarial Neural Computer for de Novo Molecular Design; Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFÎ² enhance the efficacy of cancer immunotherapy; Potential non-covalent SARS-CoV-2 3C-like protease inhibitors designed using generative deep learning approaches and reviewed by human medicinal chemist in virtual reality; Entangled conditional adversarial autoencoder for de novo drug discovery; Brain-computer interface based on generation of visual images; Adversarial Threshold Neural Computer for Molecular de Novo Design; Genetics and epigenetics of aging and longevity; Gadd45 proteins: relevance to aging, longevity and age-related pathologies; Machine learning on human muscle transcriptomic data for biomarker discovery and tissue-specific drug target identification; DNA repair in species with extreme lifespan differences; Population specific biomarkers of human aging: a big data study using South Korean, Canadian, and Eastern European patient populations
